Global /United States /Healthcare /Biotechnology /PTIX

Protagenic Therapeutics, Inc.

PTIX

• NASDAQ: PTIX • Delayed

0.7400USD -43%

As of 13 June 2026, Protagenic Therapeutics, Inc. has a market cap of $1.43M USD, ranking #47885 globally and #6124 in the United States. It ranks #4245 in the Healthcare sector, and #827 in the Biotechnology industry.

Global Rank

47885

Country Rank

6124

Sector Rank

4245

Industry Rank

827

Key Stats

Market Cap

$1.43MUSD

Enterprise Value

$2.71MUSD

Company Profile

Country (HQ)

United States

Sector

Healthcare

Industry

Biotechnology

CEO

Barrett Evans open_in_new

Employees

Founded

1994

IPO

05 Jan 2016

Website

phytanix.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-43%	-44%	-62%	-78%	-79%	-43%	-90%	-97%	-99%

News

PTIX Analyst Forecasts

Markets

Exchange	Ticker	Price	Quotes
NASDAQ MIC: XNAS PRIMARY	PTIX Protagenic Therapeutics Inc ISIN: US74365N3017 Shares Out.: Shares Outstanding: 1.928M¹ Shares Float: 1.842M² TV: TradingView: NASDAQ: PTIX SA: Stock Analysis: NASDAQ: PTIX YF: Yahoo Finance: PTIX GF: Google Finance: NASDAQ: PTIX NQ: NASDAQ: PTIX BA: Barron's: PTIX MS: Morningstar: XNAS: PTIX	0.7400 USD	TV: TradingView: NASDAQ: PTIX SA: Stock Analysis: NASDAQ: PTIX YF: Yahoo Finance: PTIX GF: Google Finance: NASDAQ: PTIX NQ: NASDAQ: PTIX BA: Barron's: PTIX MS: Morningstar: XNAS: PTIX

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Protagenic Therapeutics, Inc.

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.

Similar Companies

Industry: Biotechnology (United States)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 13M%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 11M%	19.0	United States
Natera, Inc. NASDAQ: NTRA	$27.6B 2M%	-	United States
IQVIA Holdings Inc. NYSE: IQV	$26.3B 2M%	20.0	United States
United Therapeutics Corp. NASDAQ: UTHR	$25.03B 2M%	20.4	United States
Moderna, Inc. NASDAQ: MRNA	$18.13B 1M%	-	United States

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
argenx SE EBR: ARGX	$47.84B 41.39B EUR 3M%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.84B 68.19T KRW 3M%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.36B 60.27B AUD 3M%	29.3	Australia
Lonza Group AG SIX: LONN	$42.3B 33.71B CHF 3M%	37.2	Switzerland
Celltrion, Inc. KRX: 068270	$28.11B 42.76T KRW 2M%	43.8	South Korea
BioNTech SE NASDAQ: BNTX	$25.69B 2M%	-	Germany

chevron_leftBack